ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0REU Pharma Equity Group A/s

0.40
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Pharma Equity Group A/s LSE:0REU London Ordinary Share DK0061155009 PHARMA EQUITY GROUP ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.40 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investors, Nec 0 -24.61M -0.0241 -16.60 409.19M

Changes to the Board of Directors in Pharma Equity Group 

15/06/2023 11:00am

GlobeNewswire Inc.


Pharma Equity Group A/s (LSE:0REU)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more Pharma Equity Group A/s Charts.
Changes to the Board of Directors in Pharma Equity Group 

15 June 2023 

Announcement no. 35 

Changes to the Board of Directors in Pharma Equity Group 

Today, the company has received notice that the Chairman of the Board of Directors, Peter Mørch Eriksen and Board Member Ole Larsen have decided to resign from the Board with immediate effect.  

The Board has thereafter constituted itself with Christian Vinding Thomsen as Chairman of the Board of Directors. 

For further information, please contact:     

Christian Vinding Thomsen, Chairman of the Board of Directors of Pharma Equity Group A/S, phone: 2622 7222 

Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14 

About Pharma Equity Group A/S  

Pharma Equity Group A/S is a listed company on the Nasdaq Copenhagen Stock Exchange, with a focus on early investment in innovative life science companies (in or before phase 2) that develop technologies and therapies that have the potential to improve human health and quality of life.   

Pharma Equity Group A/S portfolio currently includes Reponex Pharmaceuticals A/S. Reponex Pharmaceuticals A/S is a clinical-stage biopharmaceutical company dedicated to the development of novel, effective treatments for diseases that have significant patient and social impact. 

1 Year Pharma Equity Group A/s Chart

1 Year Pharma Equity Group A/s Chart

1 Month Pharma Equity Group A/s Chart

1 Month Pharma Equity Group A/s Chart

Your Recent History

Delayed Upgrade Clock